Literature DB >> 15362202

The diagnostic significance of the detection of cytokeratin 19 mRNA by quantitative RT-PCR in benign and malignant pleural effusions.

Feng Xu1, Jie Chen, Hua-hao Shen, Xuan-ding Wang, Jiang Shan.   

Abstract

OBJECTIVE: To evaluate the diagnostic significance of detecting cytokeratin 19 (CK19) mRNA by quantitative reverse transcription polymerase chain reaction (RT-PCR) in benign and malignant pleural effusions.
METHODS: CK19 mRNA was examined by quantitative RT-PCR and CK19 was detected by Enzyme-linked immunoadsorbent assay (ELISA) in 32 patients with malignant pleural effusions and 35 patients with benign pleural effusions.
RESULTS: On the threshold of 200 copies/microl, the positive rate of CK19 mRNA in patients with malignant pleural effusions was 62.5%. The positive rates of CK19 mRNA and CK19 in the malignant pleural effusions were significantly higher than those in the benign group (P<0.01). Furthermore, the positive rate of CK19 mRNA was higher than that of CK19 in the malignant group (P<0.05).
CONCLUSION: Detection of CK19 mRNA can be a promising diagnostic marker in differential diagnosis of benign and malignant pleural effusions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362202      PMCID: PMC1388735          DOI: 10.1631/jzus.2004.1286

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci        ISSN: 1009-3095


  7 in total

1.  Detection of circulating tumour cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique.

Authors:  L S Wong; J E Cantrill; S Odogwu; A G Morris; I A Fraser
Journal:  Br J Surg       Date:  1997-06       Impact factor: 6.939

2.  Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease.

Authors:  M Mori; K Mimori; H Ueo; N Karimine; G F Barnard; K Sugimachi; T Akiyoshi
Journal:  Int J Cancer       Date:  1996-12-11       Impact factor: 7.396

3.  Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation.

Authors:  Chiou-Chung Yuan; Peng-Hui Wang; Heung-Tat Ng; Ywan-Feng Li; Tze-Sing Huang; Ching-Yi Chen; Lai-Chen Tsai; Wen-Yuann Shyong
Journal:  Gynecol Oncol       Date:  2002-04       Impact factor: 5.482

4.  Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression.

Authors:  I H Wong; W Yeo; A T Chan; P J Johnson
Journal:  Cancer Lett       Date:  2001-01-10       Impact factor: 8.679

5.  Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.

Authors:  S Noguchi; T Aihara; K Motomura; H Inaji; S Imaoka; H Koyama
Journal:  Cancer       Date:  1996-09-15       Impact factor: 6.860

6.  High false-positive rate of cytokeratin-19 in detecting circulating tumor cells for nasopharyngeal carcinoma.

Authors:  Ruey-Ho Kao; Li-Chih Huang
Journal:  Chang Gung Med J       Date:  2002-04

7.  Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel.

Authors:  M A Lockett; P L Baron; P H O'Brien; B M Elliott; J G Robison; N Maitre; J S Metcalf; D J Cole
Journal:  J Am Coll Surg       Date:  1998-07       Impact factor: 6.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.